Table 1.
Patient demographics
| Age at Diagnosis (years) | |
| Median (range) | 54 (21–90+) |
| Sex, n (%) | |
| Male | 28 (59.6%) |
| Female | 19 (40.4%) |
| Follow-Up (months) | |
| Median (range) | 98 (3-555) |
| Sample Type, n (%) | |
| Primary | 40 (85.1%) |
| Recurrent | 7 (14.9%) |
| Hyams Grade, n (%) | |
| I | 7 (14.9%) |
| II | 22 (46.8%) |
| III | 12 (25.5%) |
| IV | 5 (10.6%) |
| Unknown | 1 (2.1%) |
| Modified Kadish Stage, n (%) | |
| A | 4 (8.5%) |
| B | 4 (8.5%) |
| C | 34 (72.3%) |
| D | 5 (10.6%) |
| Dulgerov Stage Sample, n (%) | |
| T1 | 8 (17.0%) |
| T2 | 13 (27.7%) |
| T3 | 12 (25.5%) |
| T4 | 10 (21.3%) |
| Unknown | 4 (8.5%) |
| Presenting Symptoms, n (%) | |
| Dural infiltration | 18 (38.3%) |
| Orbital involvement | 3 (6.4%) |
| Nasal obstruction | 24 (51.1%) |
| Rhinorrhea | 9 (19.1%) |
| Epistaxis | 20 (42.6%) |
| Anosmia | 11 (23.4%) |
| Headache | 8 (17.0%) |
| Epiphora | 1 (2.1%) |
| Diplopia | 1 (2.1%) |
| Pain | 8 (17.0%) |